HB3848 amends the Illinois Newborn Metabolic Screening Act to require the Department of Public Health, subject to appropriation, to provide screening tests for rare blood disorders for all newborns in the state. The bill gives the Department discretion to determine which rare blood disorders are included in the screening program.
The measure also requires the Department of Public Health to adopt rules to implement the new screening requirement. Because the bill is tied to appropriations, the mandate would depend on funding being made available by the General Assembly.
Impact
If enacted, HB3848 would expand the state’s newborn screening program by adding rare blood disorder testing to the list of screenings provided to newborns under the Newborn Metabolic Screening Act. It would place implementation responsibility on the Illinois Department of Public Health and require the agency to establish rules, potentially affecting hospitals, birthing centers, newborn care providers, and families statewide. The bill creates a new statutory section, 410 ILCS 240/3.7, within the existing act.
Sentiment
There is no recorded committee transcript or vote history provided, so the bill’s sentiment cannot be measured from debate or roll call data. Based on the bill text and caption, it appears to be a public health measure aimed at early detection and treatment of serious conditions in newborns, which generally suggests a favorable policy purpose. However, the appropriation contingency indicates that support may depend on funding considerations.
Contention
No specific points of contention are documented in the provided materials. The main practical issue is the bill’s dependence on appropriation, which could raise questions about cost, implementation capacity, and which rare blood disorders the Department should include. Any disagreement would likely center on fiscal impact, administrative rulemaking, and the scope of the screening panel rather than the underlying public health goal.